MoneyWorks4Me

Smruthi Organics - Quaterly Results

13 Aug 2025 Evaluate
The sales for the June 2025 quarter moved down -30.36% to Rs. 189.92 millions as compared to Rs. 272.73 millions during the year ago period.The Net Loss for the quarter ended June 2025 is Rs. -10.95 millions as compared to Net Loss of Rs. -9.22 millions of corresponding quarter ended June 2024A decline of 3.17 millions was observed in the OP in the quarter ended June 2025 from 4.48 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 189.92 272.73 -30.36 189.92 272.73 -30.36 1260.08 1276.43 -1.28
Other Income 0.88 0.02 4300.00 0.88 0.02 4300.00 0.89 0.76 17.11
PBIDT 3.17 4.48 -29.24 3.17 4.48 -29.24 122.71 120.31 1.99
Interest 4.62 4.08 13.24 4.62 4.08 13.24 18.70 14.08 32.81
PBDT -1.45 0.40 -462.50 -1.45 0.40 -462.50 104.01 106.23 -2.09
Depreciation 14.08 12.94 8.81 14.08 12.94 8.81 55.01 56.53 -2.69
PBT -15.53 -12.54 23.84 -15.53 -12.54 23.84 49.00 49.70 -1.41
TAX -4.58 -3.32 37.95 -4.58 -3.32 37.95 13.37 13.79 -3.05
Deferred Tax -4.53 -3.32 36.45 -4.53 -3.32 36.45 -0.32 -2.27 -85.90
PAT -10.95 -9.22 18.76 -10.95 -9.22 18.76 35.63 35.91 -0.78
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 1.67 1.64 1.61 1.67 1.64 1.61 9.74 9.43 3.32
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..